아시아태평양의 심장 AI 모니터링 및 진단 시장 : 분석 및 예측(2023-2032년)

“The Asia-Pacific Cardiac AI Monitoring and Diagnostics Market Expected to Reach $2,154.6 Million by 2032.”

Introduction to Asia-Pacific Cardiac AI Monitoring and Diagnostics Market

The Asia-Pacific cardiac AI monitoring and diagnostics market was valued at $200.4 million in 2023 and is anticipated to reach $2,154.6 million by 2032, witnessing a CAGR of 30.20% during the forecast period 2023-2032. Growth in the cardiac AI monitoring and diagnostics market is driven by widespread cardiovascular diseases, government support for AI in healthcare, increasing cardiology-focused AI research, more regulatory approvals for AI cardiac devices, and advances in AI cardiac diagnostics technology.

Market Introduction

The Asia-Pacific (APAC) market for cardiac AI monitoring and diagnostics is witnessing significant growth, driven by several key factors. The region faces a high burden of cardiovascular diseases, fueled by aging populations and increasing prevalence of lifestyle-related risk factors like diabetes and hypertension. This has heightened the demand for advanced diagnostic and monitoring tools. Governments across APAC are increasingly recognizing the potential of AI in healthcare, leading to supportive policies and investments in AI technology. Additionally, the region is seeing a surge in healthcare technology research, including AI applications in cardiology, making advanced diagnostics more accessible and efficient. Furthermore, the increasing number of regulatory approvals for AI-based cardiac diagnostic devices reflects a growing trust in their effectiveness and safety. Technological advancements in AI are enhancing the precision and accuracy of cardiac diagnostics, catering to the region's diverse and expanding healthcare needs.

Market Segmentation:

Segmentation 1: by Product

• Software
• Hardware

Segmentation 2: by Type

• Cardiac Diagnostics
  • Imaging
  • ECG-Based
  • Others
• Cardiac Monitoring

Segmentation 3: by Application

• Ischemic Heart Disease/CAD
• Cardiac Arrhythmias
• Ischemic Stroke
• Others

Segmentation 4: by End User

• Hospitals
• Diagnostic Centers
• Other End Users

Segmentation 5: by Country

• China
• Japan
• India
• Australia
• South Korea
• Rest-of-Asia-Pacific

How Can This Report Add Value to an Organization?

Product/Innovation Strategy: The APAC cardiac AI monitoring and diagnostics market has been extensively segmented based on various categories, such as products, types, applications, end users, and regions. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Table of Contents

Executive Summary

1. Market

• 1.1. Market Outlook
  • 1.1.1. Product Definition
  • 1.1.2. Inclusion Criteria
  • 1.1.3. Exclusion Criteria
  • 1.1.4. Overview
    • 1.1.4.1. Market Size and Growth Potential

2. Industry Outlook

• 2.1. Key Trends
  • 2.1.1. Rising Number of Startups in the Market
  • 2.1.2. Increased Awareness Regarding Preventative Measures and Personalized Treatment
  • 2.1.3. Growing Demand for Wearable Sensors for Cardiac Monitoring Leading to Increased Adoption of AI-Enabled Solutions for Home-Based Care
• 2.2. Opportunity Assessment
• 2.3. Regulatory Framework
  • 2.3.1. Regulatory Framework for Artificial Intelligence-Based FDA-Approved Medical Devices and Algorithms
  • 2.3.2. Regulatory Framework in Japan
  • 2.3.3. Regulatory Framework in China
• 2.4. Patent Analysis
  • 2.4.1. Awaited Technological Developments
    • 2.4.1.1. Patent Analysis (by Country)
    • 2.4.1.2. Patent Analysis (by Year)
• 2.5. Business Models
• 2.6. Case Studies
  • 2.6.1. Case Study 1: Ultromics Limited
    • 2.6.1.1. The EchoGo System
      • 2.6.1.1.1. Developement
      • 2.6.1.1.2. Use Case and Reliability
    • 2.6.1.2. A Success Story
    • 2.6.1.3. Partners and Recognitions
  • 2.6.2. Case Study 2: CorVista Health, Inc.
    • 2.6.2.1. The CorVista System
    • 2.6.2.2. A Success Story
• 2.7. Ongoing Clinical Trials
• 2.8. Funding Scenario
• 2.9. End User Perception
• 2.1. Entry Barriers for New Entrants

3. Impact of COVID-19

• 3.1. Impact on the Overall Market
• 3.2. Pre-COVID-19 Scenario
• 3.3. During COVID-19 Scenario
• 3.4. Post COVID-19 Scenario

4. Regions

• 4.1. Asia-Pacific Cardiac AI Monitoring and Diagnostics Market
  • 4.1.1. Key Findings and Opportunity Assessment
  • 4.1.2. Digital Adoption
  • 4.1.3. Market Dynamics
    • 4.1.3.1. Impact Analysis
  • 4.1.4. Market Sizing and Forecast
    • 4.1.4.1. Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Product)
    • 4.1.4.2. Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Type)
      • 4.1.4.2.1. Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
    • 4.1.4.3. Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Application)
    • 4.1.4.4. Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by End User)
    • 4.1.4.5. Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Country)
      • 4.1.4.5.1. Japan
        • 4.1.4.5.1.1. Market Dynamics
        • 4.1.4.5.1.2. Market Size and Forecast
        • 4.1.4.5.1.2.1. Japan Cardiac AI Monitoring and Diagnostics Market (by Product)
        • 4.1.4.5.1.2.2. Japan Cardiac AI Monitoring and Diagnostics Market (by Type)
        • 4.1.4.5.1.2.2.1. Japan Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
        • 4.1.4.5.1.2.3. Japan Cardiac AI Monitoring and Diagnostics Market (by Application)
        • 4.1.4.5.1.2.4. Japan Cardiac AI Monitoring and Diagnostics Market (by End User)
      • 4.1.4.5.2. China
        • 4.1.4.5.2.1. Market Dynamics
        • 4.1.4.5.2.2. Market Size and Forecast
        • 4.1.4.5.2.2.1. China Cardiac AI Monitoring and Diagnostics Market (by Product)
        • 4.1.4.5.2.2.2. China Cardiac AI Monitoring and Diagnostics Market (by Type)
        • 4.1.4.5.2.2.2.1. China Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
        • 4.1.4.5.2.2.3. China Cardiac AI Monitoring and Diagnostics Market (by Application)
        • 4.1.4.5.2.2.4. China Cardiac AI Monitoring and Diagnostics Market (by End User)
      • 4.1.4.5.3. India
        • 4.1.4.5.3.1. Market Dynamics
        • 4.1.4.5.3.2. Market Size and Forecast
        • 4.1.4.5.3.2.1. India Cardiac AI Monitoring and Diagnostics Market (by Product)
        • 4.1.4.5.3.2.2. India Cardiac AI Monitoring and Diagnostics Market (by Type)
        • 4.1.4.5.3.2.2.1. India Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
        • 4.1.4.5.3.2.3. India Cardiac AI Monitoring and Diagnostics Market (by Application)
        • 4.1.4.5.3.2.4. India Cardiac AI Monitoring and Diagnostics Market (by End User)
      • 4.1.4.5.4. Australia
        • 4.1.4.5.4.1. Market Dynamics
        • 4.1.4.5.4.2. Market Size and Forecast
        • 4.1.4.5.4.2.1. Australia Cardiac AI Monitoring and Diagnostics Market (by Product)
        • 4.1.4.5.4.2.2. Australia Cardiac AI Monitoring and Diagnostics Market (by Type)
        • 4.1.4.5.4.2.2.1. Australia Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
        • 4.1.4.5.4.2.3. Australia Cardiac AI Monitoring and Diagnostics Market (by Application)
        • 4.1.4.5.4.2.4. Australia Cardiac AI Monitoring and Diagnostics Market (by End User)
      • 4.1.4.5.5. South Korea
        • 4.1.4.5.5.1. Market Dynamics
        • 4.1.4.5.5.2. Market Size and Forecast
        • 4.1.4.5.5.2.1. South Korea Cardiac AI Monitoring and Diagnostics Market (by Product)
        • 4.1.4.5.5.2.2. South Korea Cardiac AI Monitoring and Diagnostics Market (by Type)
        • 4.1.4.5.5.2.2.1. South Korea Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
        • 4.1.4.5.5.2.3. South Korea Cardiac AI Monitoring and Diagnostics Market (by Application)
        • 4.1.4.5.5.2.4. South Korea Cardiac AI Monitoring and Diagnostics Market (by End User)
      • 4.1.4.5.6. Rest-of-Asia-Pacific
        • 4.1.4.5.6.1. Market Size and Forecast
        • 4.1.4.5.6.1.1. Rest-of-Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Product)
        • 4.1.4.5.6.1.2. Rest-of-Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Type)
        • 4.1.4.5.6.1.2.1. Rest-of-Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
        • 4.1.4.5.6.1.3. Rest-of-Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Application)
        • 4.1.4.5.6.1.4. Rest-of-Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by End User)

5. Markets - Competitive Benchmarking & Company Profiles

• 5.1. Cardiac AI Monitoring and Diagnostics Active Players Ecosystem
• 5.2. Key Strategies and Developments
  • 5.2.1. Regulatory and Legal Activities
• 5.3. Company Profiles
  • 5.3.1. Canon Inc.
    • 5.3.1.1. Company Overview
    • 5.3.1.2. Role of Canon Inc. in the Cardiac AI Monitoring and Diagnostics Market
    • 5.3.1.3. Financials
    • 5.3.1.4. Analyst Perception